
2.52 Delayed Data As of Jan 22 | ![]() Today’s Change | 1.06 Today|||52-Week Range 3.72 | 0.00% Year-to-Date |
Aclaris (ACRS) Up on Preliminary Data for MK2 Inhibitor in RA Jan 20 / Zacks.com - Paid Partner Content |
Previous close | 2.53 |
Today’s open | 2.47 |
Day’s range | 2.44 - 2.56 |
Volume | 58,715 |
Average volume (3 months) | 4,319,937 |
Market cap | $66.0M |
Earnings growth (last year) | +17.27% |
Earnings growth (this year) | +53.49% |
Earnings growth (next 5 years) | -25.00% |
Revenue growth (last year) | -- |
P/E ratio | NM |
Price/Sales | -- |
Price/Book | 0.95 |
Today’s change | Today’s % change | |
---|---|---|
SVRASavara Inc | +0.01 | +0.56% |
MRKRMarker Therapeutics ... | +0.03 | +1.48% |
--Ecogreen Internation... | -0.00 | -0.78% |
QLGNQualigen Therapeutic... | +0.01 | +0.29% |
Next reporting date | March 10, 2021 |
EPS forecast (this quarter) | -$0.24 |
Annual revenue (last year) | $0.00 |
Annual profit (last year) | -$25.5M |
Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Modi'in, Hamerkaz |